Breaking the 'mucus barrier' with a new drug delivery systemAugust 20, 2008Chemical engineers from Johns Hopkins University have broken the "mucus barrier," engineering the first drug-delivery particles capable of passing through human mucus - regarded by many as nearly impenetrable - and carrying medication that could treat a range of diseases. Those conditions include lung cancer, cervical cancer and cystic fibrosis, the research noted in a presentation scheduled for the 236th National Meeting of the American Chemical Society. "We studied the properties of disease-causing viruses that evolved to infect mucosal surfaces to engineer a coating that enables our drug delivery particles to penetrate mucus layers in minutes. In our new work, we have improved the coatings considerably to allow faster penetration for a wider array of particle sizes," says lead presenter Samuel K. Lai, Ph.D. Mucus, the slippery secretion lining the lung airways, surface of the eye, gastrointestinal tract, and female reproductive tract, may seem delicate. But it is a tenacious barrier, effectively keeping out most pathogens and limiting infections. "Mucus has evolved to be a highly efficient barrier," says Justin Hanes, professor of chemical & biomolecular engineering at Johns Hopkins University, the lead investigator of the study. "For example, we constantly inhale particles into our lungs, but they typically stick to mucus rather than penetrate it. Particles that stick are removed rapidly from the lungs on a mucus 'conveyor belt,' and are swallowed and sterilized in the gut. Mucus barriers protect us from constant infection, as well as everyday things like the millions of particles in the black cloud emitted from a bus when it takes off from a stop." Unfortunately, mucus also prevents the passage of many beneficial drugs. And when the mucus gets thicker - most notably in diseases like chronic sinusitis, cystic fibrosis and chronic obstructive pulmonary disorder - drug treatment of the lungs and other mucus-lined areas becomes more difficult. Lai explained that coating drug-loaded nanoparticles with an inexpensive polymer material allows particles to pass through the mucus linings. With this mucus-penetrating mechanism, drugs could be delivered locally and with enhanced durations to treat diseases at mucosal surfaces. In collaboration with Richard Cone, professor of biophysics at Johns Hopkins, the work also opens the door to more targeted drug delivery - including improved chemotherapy for cervical and lung cancer patients. For inspiration in their quest to breech mucus, Hanes and colleagues took a lesson from Mother Nature - specifically viruses capable of infecting mucosal surfaces. Some of these viruses were able to pass through the dense, net-like mesh of mucus as if it were water. The researchers found that the spaces between the "threads" of the mucus mesh were much larger than previously thought, providing an opportunity for drug particles that do not adhere to mucus to pass through and avoid rapid clearance . "If a particle is small enough and not adhesive, then it can get through the mucus net - that's how some viruses penetrate mucus barriers," says Hanes. The team found that a polymer known as polyethylene glycol, or PEG, could coat individual drug particles and imbue them with the same properties as these mucus-breeching viruses. "PEG is one of the most widely used polymers for therapeutic applications," Lai explains. It's an FDA approved polymer that's been in use in humans for over 25 years - it's known to be very safe." By encapsulating drugs in mucus-penetrating particles, drug companies could expand the realm of treatment options for many diseases. "For example, cervical cancer patients could locally apply chemo drugs inside mucus-penetrating particles, which would then deliver the drug locally in the female reproductive tract at efficient concentrations over prolonged periods of time, instead of delivering it everywhere else in the body. That could drastically reduce the side effects as well as prolong the presence of drugs at the target site," says Lai. And in the case of patients with cystic fibrosis -which causes thick mucus buildup in the lungs - mucus-penetrating drugs could create more effective therapies to fight the disease. This could improve the quality of life for 70,000 cystic fibrosis sufferers worldwide. "Eventually, we seek to engineer systems where a drug could be delivered to a specific tissue or set of cells anywhere in the body - we want to make that possible." American Chemical Society |
|||||||||||||||||||||
| Related Drug Delivery System Current Events and Drug Delivery System News Articles An exquisite container In campy old movies, Lucretia Borgia swans around emptying powder from her ring into wine glasses carelessly left unattended. The poison ring is usually a confection of gold filigree holding a cabochon or faceted gemstone that can be broken to empty the ring's contents. It is invariably enormous - so large it is rather odd nobody seems to notice it. Killing Cancer Like a Vampire Slayer Like vampires, cancer tumors require an ample supply of blood to stay alive. Without fresh blood for sustenance, cancer cells shrivel up like raisins and die. New cancer drug delivery system is effective and reversible For cancer drug developers, finding an agent that kills tumor cells is only part of the equation. The drug must also spare healthy cells, and - ideally - its effects will be reversible, to cut short any potentially dangerous side effects. Biodegradable gel being studied as a treatment for esophageal cancer Gastroenterologists at Rush University Medical Center are studying the safety and efficacy of a new system for delivering chemotherapy for patients with esophageal cancer, a rare, but deadly disease that attacks the throat. Self-assembling nano-fiber gel delivers high concentrations of clinically approved drugs Two teams of scientists from Harvard-MIT Division of Health Science and Technology (HST) at Brigham and Women's Hospital have developed a new self-assembling hydrogel drug delivery system that is biocompatible, efficient at drug release, and easy to tailor. Biodegradable polymers show promise for improving treatment of acute inflammatory diseases A family of biodegradable polymers called polyketals and their derivatives may improve treatment for such inflammatory illnesses as acute lung injury, acute liver failure and inflammatory bowel disease by delivering drugs, proteins and snips of ribonucleic acid to disease locations in the body. Cancer drug delivery research at Case Western Reserve University cuts time from days to hours Researchers at Case Western Reserve University have developed a technique that has the potential to deliver cancer-fighting drugs to diseased areas within hours, as opposed to the two days it currently takes for existing delivery systems. Key Found to Breakthrough Drug for Clot Victims A team of researchers at Oregon Health & Science University and Washington University in St. Louis have described for the first time the mechanism that gives a mutant enzyme molecule that they have engineered - and patented - the potential to become a breakthrough drug for treating heart attacks and strokes. Developing a modular, nanoparticle drug delivery system There are two aspects to creating an effective drug: finding a chemical compound that has the desired biological effect and minimal side-effects and then delivering it to the right place in the body for it to do its job. Novel 3-D cell culture model shows selective tumor uptake of nanoparticles A nanoparticle drug delivery system designed for brain tumor therapy has shown promising tumor cell selectivity in a novel cell culture model devised by University of Nottingham scientists. More Drug Delivery System Current Events and Drug Delivery System News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||